One Two
Sie sind hier: Startseite Publikationen

Publikationen

2019

 

Šribar D, Grabowski M, Murgueitio MS, Bermudez M, Weindl G, Wolber G (2019) Identification and characterization of a novel chemotype for human TLR8 inhibitors. Eur J Med Chem 179:744-752. doi: 10.1016/j.ejmech.2019.06.084


Schramm S, Agnetta L, Bermudez M, Gerwe H, Irmen M, Holze J, Littmann T, Wolber G, Tränkle C, Decker M (2019) Novel BQCA- and TBPB-Derived M1 Receptor Hybrid Ligands: Orthosteric Carbachol Differentially Regulates Partial Agonism. ChemMedChem. doi: 10.1002/cmdc.201900283
 

Pfalzgraff A, Correa W, Heinbockel L, Schromm AB, Lübow C, Gisch N, Martinez-de-Tejada G, Brandenburg K, Weindl G (2019) LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses. Biochim Biophys Acta Mol Cell Biol Lipids. doi: 10.1016/j.bbalip.2019.05.018
 

Pfalzgraff A, Weindl G (2019) Intracellular lipopolysaccharide sensing as a potential therapeutic target for sepsis. Trends Pharmacol Sci 40:187-197. doi: 10.1016/j.tips.2019.01.001


Correa W, Heinockel L, Martinez-de-Tejada G, Sanchez S, Garidel P, Schürholz T, Mier W, Dupont A, Hornef M, Gutsmann T, Mauss K, Weindl G, Brandenburg K (2019) Synthetic anti-lipopolysaccharide peptides (SALP) as effective inhibitors of pathogen-associated molecular patterns (PAMPs). Adv Exp Med Biol 1117:111-129. doi: 10.1007/978-981-13-3588-4_8
 

Klaschik K, Hauke J, Neidhardt G, Tränkle C, Surowy HM, Heilmann-Heimbach S, Rappl G, Mangold E, Arnold N, Niederacher D, Sutter C, Burwinkel B, Engel C, Wappenschmidt B, Meindl A, Ernst C, Weber-Lassalle K, Weber-Lassalle N, Schmidt S, Borde J, Schmutzler RK, Hahnen E, Pohl-Rescigno E (2019) The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers. Int J Cancer 144:1761-1763. doi: 10.1002/ijc.32016

 



Eine vollständige Liste der Publikationen von Herrn Prof. Dr. Günther Weindl und Herrn PD Dr. Christian Tränkle können Sie über PubMed abrufen.

 

 

 

 

 

 

Artikelaktionen